Fact CheckerSign in

NCT07173829Recruiting

A Study to Better Understand the Biological and Molecular Mechanisms Involved in Glioblastoma Recurrence and Progression

A Prospective Study to Better Understand the Molecular, Immune and Metabolic Mechanisms Involved in Glioblastoma Recurrence and Progression, in the Aim to Identify New Therapeutic Targets and to Improve Current Therapies

Source: ClinicalTrials.gov · Last updated 7 Aug 2026

Brief summary (registry, in English)

BORDEAUX-GLIO is a prospective, monocentric study which will describe the molecular, immune and metabolic pathways involved in the progression and relapse of glioblastoma, using blood and tumor samples from patients who have undergone surgery for newly diagnosed or recurrent glioblastoma in the center.

Status (registry)
Recruiting
Study type
Observational
Enrollment
45 (estimated)
First submitted
2 Aug 2023
Start date
22 Oct 2025
Primary completion date
Oct 2031
Lead sponsor
University Hospital, Bordeaux
Diseases
Glioblastoma
NCT number
NCT07173829

What you commit to

  • Study type: Observational
  • Planned participants: 45
  • From 22 Oct 2025 to the primary completion date, Oct 2031
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patients deprived of their liberty by judicial or administrative decision, or under psychiatric care

Other

  • Patients under guardianship, curatorship or protective supervision
  • Taking immunosuppressants
  • Pregnant or breast-feeding women

Who the study is looking for

  • Patients of 18 years or older, with highly suspected glioblastoma on neuro-imagery
  • Planned surgical tumor resection,
  • No objection to participate in research
  • Signed genetic consent

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
CHU de Bordeaux
Coordinator of this site? Confirm its status
BordeauxFranceRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.